ES2054942T3 - Procedimiento para la determinacion de fructuosaminas. - Google Patents

Procedimiento para la determinacion de fructuosaminas.

Info

Publication number
ES2054942T3
ES2054942T3 ES89113171T ES89113171T ES2054942T3 ES 2054942 T3 ES2054942 T3 ES 2054942T3 ES 89113171 T ES89113171 T ES 89113171T ES 89113171 T ES89113171 T ES 89113171T ES 2054942 T3 ES2054942 T3 ES 2054942T3
Authority
ES
Spain
Prior art keywords
determination
fructuosamines
procedure
solution
fructosamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89113171T
Other languages
English (en)
Inventor
Bernd Dr Med Vogt
Hans-Dieter Dr Rer Na Lessmann
Christian Dr Rer Nat Klein
Wolfgang Treiber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Application granted granted Critical
Publication of ES2054942T3 publication Critical patent/ES2054942T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/904—Oxidation - reduction indicators
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/104998—Glucose, ketone, nitrate standard or control
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/105831—Protein or peptide standard or control [e.g., hemoglobin, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]
    • Y10T436/144444—Glucose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Diabetes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PARA DETERMINAR FRUCTOSAMINA EN LIQUIDOS CORPORALES, SE USA EN EL CALIBRADO COMO SOLUCION STANDARD UNA SOLUCION QUE CONTIENE UN PEPTIDO O PROTEINA, CUYAS UNIDADES DE AMINOACIDO COMO MINIMO AL 25% DE LISINA Y/O ORNITINA Y ESTO EN FORMA GLICOSILADA.
ES89113171T 1988-07-19 1989-07-18 Procedimiento para la determinacion de fructuosaminas. Expired - Lifetime ES2054942T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3824562A DE3824562A1 (de) 1988-07-19 1988-07-19 Verfahren zur bestimmung von fructosamin

Publications (1)

Publication Number Publication Date
ES2054942T3 true ES2054942T3 (es) 1994-08-16

Family

ID=6359099

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89113171T Expired - Lifetime ES2054942T3 (es) 1988-07-19 1989-07-18 Procedimiento para la determinacion de fructuosaminas.

Country Status (6)

Country Link
US (1) US5116762A (es)
EP (1) EP0351790B1 (es)
JP (1) JPH0726958B2 (es)
AT (1) ATE106570T1 (es)
DE (2) DE3824562A1 (es)
ES (1) ES2054942T3 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484735A (en) * 1989-08-23 1996-01-16 Northwestern University Immunoassay of glycosylated proteins employing antibody directed to reductively glycosylated N-terminal amino acids
US5206173A (en) * 1991-06-05 1993-04-27 Bedminster Bioconversion Corporation Air hood
JP3340129B2 (ja) * 1991-06-19 2002-11-05 アボツト・ラボラトリーズ グリコヘモグロビンの迅速測定
GB9116315D0 (en) * 1991-07-29 1991-09-11 Genzyme Ltd Assay
US6352835B1 (en) 1998-11-17 2002-03-05 Kyoto Daiichi Kagaku Co. Ltd. Method of measuring substance in sample using a redox reaction

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199380A (en) * 1981-12-23 1986-08-08 J R Baker Determination of serum glucose levels in blood samples
US4629692A (en) * 1982-12-06 1986-12-16 Miles Laboratories, Inc. Immunoassay for nonenzymatically glucosylated proteins and protein fragments an index of glycemia
US4761368A (en) * 1986-07-15 1988-08-02 The Rockefeller University Method and agents for measuring protein aging
DE3620817A1 (de) * 1986-06-21 1987-12-23 Boehringer Mannheim Gmbh Verfahren zur spezifischen bestimmung des serumfructosamingehalts sowie hierfuer geeignetes reagenzgemisch

Also Published As

Publication number Publication date
DE58907746D1 (de) 1994-07-07
EP0351790A3 (de) 1991-09-11
DE3824562A1 (de) 1990-02-01
ATE106570T1 (de) 1994-06-15
JPH0726958B2 (ja) 1995-03-29
JPH0269664A (ja) 1990-03-08
EP0351790B1 (de) 1994-06-01
EP0351790A2 (de) 1990-01-24
US5116762A (en) 1992-05-26

Similar Documents

Publication Publication Date Title
SE8000470L (sv) Vevnadsbindmedel och forfarande for dess framstellning samt bindmedlets anvendning
ES2055445T3 (es) Proteinas de fusion que comprenden gm-csf e il-3.
FI895382A0 (fi) Uretan-skyddade aminosyra-n -karboxianhydrider.
ES2031806T3 (es) Factor de permeabilidad vascular humano.
SE8000469L (sv) Vevnadsbindmedel och forfarande for dess framstellning samt bindmedlets anvendning
IT1232170B (it) Emulsione multipla, in particolare di emoglobina, e procedimento per la sua preparazione
NZ512083A (en) Methods of increasing lean tissue mass using OB protein compositions
NO972849L (no) Peptid p277 analoger og farmasöytiske sammensetninger som omfatter disse for behandling eller diagnostikk av diabetes
ES2054942T3 (es) Procedimiento para la determinacion de fructuosaminas.
DE68917273D1 (de) Testmethode und Gerät zur Bestimmung des gesamten Proteins.
ES2181054T3 (es) Utilizacion de producto(s) proteico(s) kgf y de producto(s) proteico(s) glp-2 para la preparacion de un medicamento.
ES2078289T3 (es) Agente para mejorar la recuperacion de anexinas.
ES2057572T3 (es) Agentes de reconocimiento.
UA26313A (uk) Засіб для замісhої терапії захворюваhь дихальhих шляхів, переважhо при сиhдромі задухи
ATE95818T1 (de) Protein-s-haeltige pharmazeutische praeparation.
NO891926L (no) Fremgangsmaate for fremstilling av stabile protein- eller peptidpreparater.
NZ229632A (en) Fructosamine assay for body fluids
ES2051916T3 (es) Procedimiento para la obtencion de formiltrimetilbiciclo(2.2.2)oct-7-enos isomeros.
IT8921981A0 (it) Preparato vitaminizzato contenente l'enzima lisozima impiegabile in zootecnica e procedimento per la sua produzione
ES2183376T3 (es) Uso de lbp para el tratamiento de la septicemia.
AU4509189A (en) Detection and quantification of (neu) related proteins in the biological fluids of humans
ATE136652T1 (de) P100 ''neu'' menschlisches protein and verwendung dieses proteins zum nachweis von preneoplasmatischen- oder neoplasmatischen beim menschen
DK222390A (da) Heparin-bindende proteiner, dna'er, der koder for saadanne proteiner, fremgangsmaade til fremstilling af proteinerne same farmaceutiske praeparater indeholdende disse
IT8804860A0 (it) Procedimento per il recupero di calore, con eventuale recupero od uso dell'umidita', ceduto direttamente o indirettamente dal corpo umano e dispositivo per la sua attuazione.
IT1219870B (it) Procedimento per ottenere amminoacidi da sostanze proteiche per uso fertilizzante

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 351790

Country of ref document: ES